Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease.

about

Placental Vascular Calcification and Cardiovascular Health: It Is Time to Determine How Much of Maternal and Offspring Health Is Written in Stone

P2860

Q56334471-9E211212-21A0-4CBF-B0E2-901169134E43

P2860

Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease.

Item

http://www.wikidata.org/entity/Q42934449

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease.

@en

Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease.

@nl

type

Item

label

Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease.

@en

Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease.

@nl

prefLabel

Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease.

@en

Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease.

@nl

P1476

Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease.

@en

P2093

Christina W Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

Association of vascular endothelial factors with cardiovascular outcome and mortality in chronic kidney disease patients: a 4-year cohort study.

Placental Growth Factor as a Predictor of Cardiovascular Events in Patients with CKD from the NARA-CKD Study.

Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure.

The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD.

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

Prognostic Impact of Placental Growth Factor on Mortality and Cardiovascular Events in Dialysis Patients.

Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes.

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

P304

115-116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1159/000439189

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

S Ananth Karumanchi

P577

2015-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26368672

http://www.w3.org/2001/XMLSchema#string

P932

4807971

http://www.w3.org/2001/XMLSchema#string

Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease.

about

P2860

P2860

Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932